A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics.
Biomedicines
Staropoli, Nicoletta N; Arbitrio, Mariamena M; Salvino, Angela A; Scionti, Francesca F; Ciliberto, Domenico D; Ingargiola, Rossana R; Labanca, Caterina C; Agapito, Giuseppe G; Iuliano, Eleonora E; Barbieri, Vito V; Cucè, Maria M; Zuccalà, Valeria V; Cannataro, Mario M; Tassone, Pierfrancesco P; Tagliaferri, Pierosandro P
Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.
Pharmacogenomics
Sissung, Tristan M TM; Deeken, John J; Leibrand, Crystal R CR; Price, Douglas K DK; Ehrlich, Sheryl S; Steinberg, Seth M SM; Liewehr, David J DJ; Dahut, William W; Figg, William D WD
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Oncotarget
Arbitrio, Mariamena M; Di Martino, Maria Teresa MT; Scionti, Francesca F; Agapito, Giuseppe G; Guzzi, Pietro Hiram PH; Cannataro, Mario M; Tassone, Pierfrancesco P; Tagliaferri, Pierosandro P
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Disease Markers
Wakil, Salma M SM; Nguyen, Cao C; Muiya, Nzioka P NP; Andres, Editha E; Lykowska-Tarnowska, Agnieszka A; Baz, Batoul B; Tahir, Asma I AI; Meyer, Brian F BF; Morahan, Grant G; Dzimiri, Nduna N